Methods for co-culturing multicellular spheroids with cells
By performing semi-open co-culture on a superhydrophobic microarray chip and optimizing Matrigel concentration and inversion time, the problems of low cell contact efficiency and cumbersome operation in existing technologies are solved, and efficient multi-cell co-culture is achieved, which is suitable for preclinical immunotherapy evaluation and new drug development.
Patent Information
- Application Number
- CN202311195336.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-09-17
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2043-09-17
AI Technical Summary
Existing multi-cell co-culture methods suffer from problems such as low cell contact efficiency, cumbersome operation, inability to recover cells, and high demand for organoids. In particular, in the clinical neoadjuvant stage, immunotherapy is frequently used but the number of puncture samples is limited, which affects efficacy evaluation and drug development.
Semi-open co-culture was carried out using a superhydrophobic microarray chip. Multicellular spheres were placed on the surface of Matrigel by inverting them, allowing them to fully contact the cells in the culture medium at the gel interface. Combined with optimized Matrigel concentration and inversion time on ice, efficient contact and interaction between organoids and immune cells were achieved.
It improves cell contact and infiltration efficiency, has good operability and recyclability, and is suitable for immunotherapy and pharmacological studies on small sample sizes, assisting in preclinical efficacy evaluation and new drug development.
Smart Images

Figure CN117264896B_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of cell biology, and in particular to a method for co-culturing multicellular spheres and cells. Background Technology
[0002] In recent years, several cell- and drug-related immunotherapies have been gradually applied in clinical practice, including immune checkpoint inhibitors such as anti-PD1 monoclonal antibodies and adoptive cell therapy. These immunotherapies have shown significant efficacy in some epithelial malignancies, including melanoma, non-small cell lung cancer, and colorectal cancer. However, to date, there is still a lack of tumor markers that can accurately predict the efficacy of immunotherapy in cancer patients. With the rise of organoid models, it is necessary to establish organoid models that can accurately assist patients in predicting the efficacy of immunotherapy.
[0003] The essence of tumor immunotherapy is to restart and maintain the tumor-immune cycle, enhance the body's immune surveillance function or locally improve the tumor immune microenvironment, thereby restoring the body's normal anti-tumor immune response and ultimately controlling and eliminating the tumor. Throughout this process, tumor cells and immune cells interact closely. Therefore, co-culture is the process of simulating the interaction between these two types of cells through organoids to evaluate the immunotherapy efficacy.
[0004] To date, most co-culture methods employ techniques such as plate-based immersion co-culture, gas-liquid interface co-culture, and matrix gel co-culture. However, these methods first require obtaining a large number of organoids, which is challenging for biopsies, especially puncture samples. Second, these co-culture methods prevent sufficient contact between organoids and immune cells, hindering the infiltration of immune cells into the organoids during co-culture, significantly reducing assessment efficiency and accuracy. Furthermore, their poor operability prevents the local recovery of organoids that have established stable interactions with immune cells, thus hindering subsequent analyses such as single-cell sequencing. Therefore, establishing a highly efficient and easily operable co-culture platform to assist in assessing immunotherapy efficacy in cancer patients is essential.
[0005] The microfluidic co-culture method uses PDMS to prepare a 3D microfluidic culture device. Tumor organoids containing a certain number of immune cells are mixed with matrix gel and injected into the central chamber of the 3D microfluidic culture device. After incubation at 37°C for 30 min, the matrix gel solidifies. Culture medium or drugs are then injected into the side chambers, and the cells are cultured in a 37°C, 5% CO2 cell culture incubator. This technique suffers from several drawbacks. Because the immune cells are encapsulated in the matrix gel, they cannot move or migrate, thus reducing the contact efficiency between the immune cells and the organoids. Furthermore, the central chamber of the tubular microfluidic chip is closed and cannot be recovered, hindering subsequent research.
[0006] The microarray co-culture method uses PDMS to prepare microtumor chips. Each chip contains three sample inlets and 1000 micropits, with an overall size of 400 μm × 400 μm × 320 μm. Fresh tumor tissue is digested into single cells, and the single-cell suspension is introduced into the microarray chip at an appropriate density and cultured in a 37°C, 5% CO2 cell culture incubator. This technique suffers from several drawbacks: the limited volume of culture medium that can be contained within the chip and the inability to change the medium result in a cell survival time of only 3 days; the lack of matrix gel makes it impossible to stabilize the interaction between tumor cells and immune cells; and the closed chip design makes washing and recovery difficult, thus hindering subsequent analysis.
[0007] The integration of microfluidics has changed the way co-culture is conducted. The high throughput and flexibility of micro-chambers have greatly reduced the number of organoids involved in each reaction condition, which is a boon for precious organoid samples with small initial quantities. However, although the current co-culture method based on microfluidic chips has obvious advantages over well plates, it also has many drawbacks such as low cell-to-cell contact efficiency and inability to recycle. It is a closed culture method. Therefore, there is an urgent need to develop a highly efficient and operable co-culture mode. Summary of the Invention
[0008] To address the aforementioned technical problems, this invention provides a method for co-culturing multicellular spheres and cells. The method involves semi-open co-culturing on a superhydrophobic microarray chip. Multicellular spheres are placed upside down on the surface of a matrix gel, and then the multicellular spheres remain on the matrix gel surface. Simultaneously, culture medium containing the cells to be cultured is added above the micro-pits of the chip. At this point, the multicellular spheres and the cells to be cultured have sufficient contact and interaction at the gel-liquid interface, achieving co-culturing of the multicellular spheres and the cells to be cultured. The semi-open co-culturing refers to the fact that, unlike closed co-culturing, the cells participating in the co-culturing can exchange oxygen with the air, thereby better promoting cell growth during the co-culturing process.
[0009] In one embodiment, the multicellular sphere is an organoid.
[0010] In one implementation, the method includes the following steps: Step 1: Mix the organoid suspension with the matrix gel to suspend the organoid in the matrix gel. At the same time, pre-cool the superhydrophobic microarray chip to prevent the matrix gel from solidifying rapidly when it comes into contact with the superhydrophobic microarray chip during the inoculation process. Step 2: Inoculate each micropit of the chip with the matrix gel containing organoids from Step 1, while maintaining the temperature at which the organoids do not solidify in the matrix gel during this inoculation process; Step 3: After step 2, the chip is inverted. During this process, the matrix adhesive is kept from solidifying. The organoid will sink to the surface of the matrix adhesive, i.e. the top of the micropit, under the action of gravity. Step 4: Rotate the inverted chip to the temperature at which the matrix adhesive solidifies, and let it stand for a period of time, during which the matrix adhesive solidifies; Step 5: Add the culture medium containing the cells to be cultured to the solidified matrix gel surface.
[0011] In one embodiment, the method further includes the following steps: in step 5, the culture medium containing the cells to be cultured is spotted onto a glass slide using an automatic spotting device; then the chip is flipped over again to align the glass slide with the chip and complete the co-culture.
[0012] In one embodiment, in step 2, sterile water is added around the chip to create a humid environment.
[0013] In one embodiment, the organoid is a tumor organoid, and the cells to be cultured are immune cells.
[0014] In one embodiment, the matrix adhesive is matrigel, tissue decellularization matrix adhesive, plant-derived matrix adhesive, or synthetic macromolecular polymer matrix adhesive.
[0015] In addition to being used in popular fields such as developmental research and tumor drug screening, organoids are widely used in regenerative medicine applications such as tissue regeneration and repair.
[0016] Matrigel is an extract of EHS mouse sarcoma and is widely used in organoid culture. However, Matrigel is not the only option for matrix gels. In addition to the commonly used BME basement membrane extract, there are also lammin, I, II, and IV collagen, which are also widely used in organoid culture.
[0017] Decellularized matrix gels, such as those prepared by Giobbe et al. (2019), use decellularized porcine small intestine to prepare hydrogel matrices. Compared to Matrigel, they provide better support for the growth and expansion of endoderm organoids, such as those of the stomach, intestine, liver, and pancreas. Using porcine small intestine-derived hydrogels to culture intestinal organoids makes perfect sense. Although it is also animal-derived, porcine small intestine material is readily available, has high yield, and is not derived from tumors, giving it significant advantages. Zafeiriou et al. (2020) used type I collagen as a matrix to prepare brain organoids.
[0018] Plant-derived matrix gels: Curvello et al., 2021, successfully cultured small intestinal organoids using a matrix gel containing 0.1% plant nanocellulose. Synthetic macromolecular polymer matrix gels: Sorrentino et al., 2020, used PEG as a backbone to integrate key ECM proteins found in the liver, such as laminin-111, type IV collagen, and fibronectin, to prepare a fully chemically synthesized matrix, which was successfully used for liver organoid culture.
[0019] In one embodiment, the macromolecular polymer matrix gel is a synthetically produced macromolecular PEG matrix gel. Jowett et al., 2021, utilized the advantage of synthetically produced PEG matrix gels in regulating stiffness, and used an ILC1 and mouse intestinal organoid co-culture system to study the remodeling of the extracellular matrix by rare cell ILC1 and its impact on the microenvironment. This simple system with clearly defined components can eliminate many interferences and disturbances, allowing the effects of ILC1 or other cells on the intestinal epithelium to be clearly manifested, rather than being drowned out by noise.
[0020] Matrigel is not the only usable matrix gel in the three-dimensional culture of organoids. Matrigel is an extract from EHS mouse sarcoma; however, this animal-derived matrix gel suffers from significant batch-to-batch variability and high cost due to its diverse components, which is detrimental to large-scale drug screening and translational medicine. With the emergence of other types of matrix gels, researchers have found that synthetically produced macromolecular polymer matrix gels such as PEG gels and various hydrogels can also maintain the normal growth of organoids. Macromolecular PEG-synthesized matrix gels offer completely controllable composition, hardness, and softness. Therefore, they have unique advantages in studying the effects of mechanical properties on organoids, and also possess stability and low cost. Such matrix gels can also be used to form a GLI co-culture mode by controlling concentration and coagulation conditions, enabling highly efficient contact with a second type of cell in the culture medium.
[0021] In three-dimensional culture, organoids are not the only type of multicellular sphere. They are spontaneously formed multicellular spheres containing various cell types derived from stem cell differentiation or tissues. Besides organoids, there are also artificially induced multicellular spheres, such as those formed by mixing immortalized cell lines with other cells in low-adhesion culture. These multicellular spheres can also participate in co-culture in matrix gels. Therefore, our gel-liquid interface co-culture model based on superhydrophobic microarray chips has broad applicability.
[0022] In one embodiment, when the matrix gel is matrigel, the organoid suspension in step 1 is mixed with the matrix gel, and the volume concentration of the matrigel is 70-90%, preferably 80-90%, and more preferably 80%.
[0023] In one embodiment, in step 3, the organoid sinks to the surface of the matrix gel under the influence of gravity for 5-15 minutes, preferably 10-15 minutes, and more preferably 10 minutes.
[0024] Existing plate-based organoid co-culture methods suffer from problems such as low efficiency of contact between the two cell types, inaccurate recovery, and large requirements for the number of organoids. However, in clinical practice, immunotherapy is often used more frequently in the neoadjuvant phase than in the adjuvant phase. Before neoadjuvant therapy, sampling is only performed by puncture, which cannot obtain a large number of organoids, thus seriously affecting preclinical treatment evaluation. Currently, chip-based co-culture technology has cumbersome operation steps, a closed system, and poor operability and recyclability, which also hinders the evaluation of immunotherapy and the development of immune-related drugs.
[0025] This invention utilizes a semi-open co-culture method on a superhydrophobic microarray chip. Organoids are placed upside down on the surface of a matrix gel, while culture medium containing immune cells is added above the micro-pits. This allows for ample contact and interaction between the organoids and immune cells at the gel-liquid interface (GLI). This GLI co-culture method significantly improves the contact and infiltration efficiency between organoids and immune cells, while also offering strong operability and recyclability. The use of a superhydrophobic microarray chip during co-culture makes this method suitable for biopsy samples, greatly aiding in the preclinical evaluation of immunotherapy efficacy in cancer patients and the development of novel immunotherapeutic drugs.
[0026] The GLI co-culture mode used in this invention optimizes Matrigel concentration and ice inversion time to place organoids on the Matrigel surface, ensuring sufficient contact between the organoids and PBMCs in the culture medium. Compared to other co-culture methods, this significantly improves the efficiency of cell-organoid interaction. Furthermore, the GLI co-culture mode based on superhydrophobic microarray chips not only offers excellent operability and recyclability but also enables immunotherapy and pharmacological studies on small samples (primarily biopsy samples), which is beneficial for assisting in preclinical efficacy evaluation and new drug development for cancer patients. Attached Figure Description
[0027] To more clearly illustrate the technical solutions in the embodiments of this application, the accompanying drawings used in the embodiments will be briefly introduced below. Obviously, the accompanying drawings described below are only some embodiments recorded in this application. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.
[0028] Figure 1 This is a schematic diagram of the GLI co-cultivation mode based on a superhydrophobic microarray chip; Figure 2 This is a diagram showing the interaction between organoids and PBMCs in GLI co-culture mode; Figure 3 This is a graph showing the results of anti-PD1 susceptibility assessment using the GLI co-culture mode. Detailed Implementation
[0029] To enable those skilled in the art to better understand the technical solutions in this application, the present invention will be further described below with reference to embodiments. Obviously, the described embodiments are only some embodiments of this application, and not all embodiments. Based on the embodiments in this application, all other embodiments obtained by those skilled in the art without creative effort should fall within the scope of protection of this application.
[0030] Example 1. Fabrication of a superhydrophobic micro-pit array chip For details on the fabrication of the superhydrophobic micro-pit array chip, please refer to the applicant's prior Chinese patent application, "Superhydrophobic Micro-pit Array Chip and its Fabrication Method and Apparatus," Chinese Patent No. 202010636603.6. In the aforementioned patent, a chip comprising a micro-pit array and a superhydrophobic coating pool is integrally injection molded. A superhydrophobic coating is added to the superhydrophobic coating pool. After the superhydrophobic coating solution evaporates, a superhydrophobic layer is formed between the micro-pits of the micro-pit array. This superhydrophobic layer refers to a hydrophobic layer whose surface has a contact angle with water or an aqueous solution greater than 150° and a roll-off angle less than 10°. This superhydrophobic layer effectively physically isolates the aqueous solutions within each micro-pit. The arrangement, size, and depth of the micro-pit array in the chip are all adjustable, achieving complete isolation between the micro-pit arrays, thus preventing cross-contamination between micro-pits and maintaining good biocompatibility. The specific fabrication process will not be elaborated upon here.
[0031] Example 2. Co-culture of lung cancer organoids and peripheral blood mononuclear cells (PBMCs) The overall process of cultivation is as follows Figure 1As shown. Taking the co-culture of lung cancer organoids and PBMCs on a superhydrophobic microarray chip as an example, the specific operation method is as follows: (1) Mix the centrifuged tumor organoid suspension with a certain volume of Matrigel so that the final Matrigel concentration reaches 80%. At the same time, place the superhydrophobic microarray chip on ice to pre-cool it to prevent Matrigel from solidifying rapidly when it comes into contact with the chip during the inoculation process; (2) Transfer the organoid suspension, PBMCs mixed with culture medium, sterile water, pre-cooled sterile chip and sealing film to a sterile humidifier. Inoculate the Matrigel mixed with organoids into each micro-pit of the chip according to a system of 400 nL per well, and add 1 Create a humid environment with about mL of sterile water. This inoculation process is completed on ice to prevent Matrigel from solidifying during the inoculation process; (3) Quickly invert the chip and let it stand on ice for 10 min. During this process, since Matrigel has not solidified, the organoids will sink to the surface of the matrix gel, i.e. the top of the micropit, under the action of gravity; (4) Turn the inverted chip from ice to room temperature and let it stand for 5-10 min. During this process, room temperature causes Matrigel to solidify; (5) Use an automatic spotting instrument to spot the culture medium containing PBMCs onto the glass slide, 2 μL for each drop; (6) Invert the chip again and use a micro alignment instrument to align the glass slide with the chip to complete the co-culture. Seal the chip with a sealing film and place it in a 37℃, 5% CO2 cell culture incubator for culture.
[0032] Example 3. Optimization of Matrigel concentration and inversion time on ice in GLI co-culture mode The successful implementation of GLI co-culture relies on two key factors: the concentration of Matrigel and the inversion time of the chip on ice. Too high a Matrigel concentration or too short an inversion time hinders organoids from settling to the surface of the chip's micropits under gravity, while too low a concentration causes the organoids to fall back to the bottom of the micropits after the chip is flipped again. Too long an inversion time negatively impacts organoid growth activity. Therefore, it is necessary to optimize the Matrigel concentration and the inversion time of the chip on ice during the co-culture process. First, we optimized the Matrigel concentration gradient. Since the chip thickness is approximately 180 μm, we calculated the percentage of organoids on the surface of the micropits (within the Z-axis range of 170-210 μm) relative to the total number of organoids in the micropores (0-210 μm). The results are shown in Table 1. When the Matrigel concentration reaches 70%, more than half of the organoids reach the micropit surface. When the Matrigel concentration is 80% and 90%, most organoids reach the surface. Since more organoids reach the surface at 80% concentration than at 90%, 80% is the most suitable concentration. Concentrations of 70-80% and 80-90% are also within acceptable ranges. Second, we optimized the ice settling time. The results are shown in Table 2. When settling on ice for 5 min, 10 min, and 15 min, and with organoids at 80%... In Matrigel, more than half of the organoids reached the surface of the micropits, with the best results observed at 10 min. The other two Matrigel concentrations showed similar results, indicating that 10 min of sedimentation on ice yielded the best effect, while 5-10 min and 10-15 min were also within acceptable ranges. Sedimentation times longer than 15 min may negatively impact drug evaluation results due to decreased cell viability. We further tracked the position of organoids in the micropits at the five concentrations after 10 min of sedimentation for seven consecutive days. The results are shown in Table 3. For the 50% and 60% concentrations, the position of organoids in the micropits gradually decreased over time. For the 80% concentration, most organoids remained stable while at the top of the micropit. At the 70% and 90% concentrations, although the organoids did not completely reach the top of the micropit, they remained relatively stable. Therefore, using an 80% Matrigel concentration and an inversion on ice for 10 min as the two inoculation conditions for GLI co-culture is most suitable, while 70-90% Matrigel concentration and an inversion time of 5-15 min are acceptable.To investigate whether the GLI co-culture mode affects organoid growth, we continuously tracked the area change rate (i.e., growth rate) of two organoid lines, 4853 and 4841, under GLI co-culture and General Culture Mode (GCM). Specifically, we tracked the same organoid for seven consecutive days and calculated its area. Since the initial area of the organoids differed, we considered day 0 as the initial value of 1, and divided the values from day 1 to day 7 by day 0. The specific values are shown in Table 4. Table 5 also shows the area difference between 4853 and 4841 under the GLI and GCM culture modes. The results show that the area difference between the two organoid lines was within 20% under both culture modes, indicating that organoids can still grow normally under the GLI co-culture mode.
[0033] Table 1: .
[0034] Table 2 .
[0035] Table 3 .
[0036] Table 4 .
[0037] Table 5 .
[0038] Example 4. Infiltration and killing of lung cancer organoids by PBMCs in GLI co-culture mode Lung cancer organoids from the same patient were co-cultured with PBMCs using the method described above. The results are shown in Table 6. Statistical analysis was performed separately for microarray pits and organoids. It was found that the number of PBMCs in contact with and infiltrating the organoids gradually increased over time, indicating that PBMCs in the culture medium can interact efficiently with lung cancer organoids in Matrigel under GLI co-culture mode. After administering the immune checkpoint inhibitor anti-PD1, we stained the organoids in the microarray pits with Calcein-AM / PI and counted the volumes of live and dead cells in the pits. Calcein-AM showed a green fluorescence signal under 488 excitation, and PI showed a red fluorescence signal under 561 excitation. Therefore, the green fluorescence volume represents the volume of live cells, and the red fluorescence volume represents the volume of dead cells. Specific values are shown in Table 7. Compared with the control group, the volume of viable cells in the treatment group was smaller, while the volume of dead cells was larger. The ratio of viable to dead cell fluorescence volume was also significantly different in the treatment group, indicating that some tumor cells in the treatment group were killed by PBMCs and the drug, consistent with clinical efficacy. This further demonstrates that the GLI co-culture mode can be used to assess the sensitivity of lung cancer tumor organoids to immune checkpoint inhibitors, assisting in predicting treatment efficacy in clinical patients. See details... Figure 2-3 .
[0039] Table 6: .
[0040] Table 7: Statistical values of green and red fluorescence in the control group and the treatment group .
[0041] The GLI co-culture mode used in this invention optimizes Matrigel concentration and ice inversion time to place organoids on the Matrigel surface, ensuring sufficient contact between the organoids and PBMCs in the culture medium. Compared to other co-culture methods, this significantly improves the efficiency of cell-organoid interaction. Furthermore, the GLI co-culture mode based on superhydrophobic microarray chips not only offers excellent operability and recyclability but also enables immunotherapy and pharmacological studies on small samples (primarily biopsy samples), which is beneficial for assisting in preclinical efficacy evaluation and new drug development for cancer patients.
[0042] It should be understood that the disclosed invention is not limited to the specific methods, schemes, and substances described, as these are all subject to variation. It should also be understood that the terminology used herein is for the purpose of describing specific embodiments only and is not intended to limit the scope of the invention, which is limited only by the appended claims.
[0043] Those skilled in the art will also recognize, or be able to identify, many equivalents of the specific embodiments of the invention described herein using no more than conventional experiments. These equivalents are also included in the appended claims.
Claims
1. A method for co-culturing multicellular spheres and cells, characterized in that, The method is semi-open co-culture on the super-hydrophobic microarray chip, the multi-cell spheroid is placed on the surface of the matrigel by the way of inverted suspension, then the multi-cell spheroid is kept on the surface of the matrigel; meanwhile, the culture medium containing the cells to be cultured is added above the micro-wells of the chip, at this time the multi-cell spheroid and the cells to be cultured are in full contact and interaction at the interface of the gel liquid, realizing the co-culture of the multi-cell spheroid and the cells to be cultured; the semi-open co-culture is different from the closed co-culture, the cells participating in the co-culture can exchange with the oxygen in the air, thus better promoting the cell growth in the co-culture process; The multi-cell spheroid is an organoid; The method comprises the following steps: Step 1: mixing the organoid suspension with the matrigel, so that the organoid is suspended in the matrigel, while pre-cooling the super-hydrophobic microarray chip to prevent the matrigel from rapidly solidifying when it meets the super-hydrophobic microarray chip during the inoculation process; Step 2: inoculating the matrigel mixed with the organoid in step 1 into each micro-well of the chip, the inoculation process is kept at a temperature at which the organoid does not solidify in the matrigel; Step 3: after step 2, the chip is immediately inverted, the matrigel is kept from solidifying during the process, and the organoid will sink to the surface of the matrigel, i.e. the top of the micro-well, under the action of gravity; Step 4: the inverted chip is transferred to the temperature at which the matrigel solidifies, and is left for a period of time, during which the matrigel solidifies; Step 5: the culture medium containing the cells to be cultured is added to the surface of the solidified matrigel.
2. The method of claim 1, wherein, The method further comprises the following steps: in step 5, the culture medium containing the cells to be cultured is spotted on a glass slide using an automatic spotter; then the chip is inverted again, the glass slide is aligned with the chip, and the co-culture is completed.
3. The method of claim 1, wherein, In step 2, sterile water is added around the chip to create a humid environment.
4. The method according to any of claims 1 to 3, characterized in that, The organoid is a tumor organoid, and the cells to be cultured are immune cells.
5. The method according to any of claims 1 to 3, characterized in that The matrigel is matrigel, tissue decellularized matrigel, plant-derived matrigel or artificially synthesized macromolecular polymer matrigel.
6. The method of claim 5, wherein, The macromolecular polymer matrigel is macromolecular PEG artificially synthesized matrigel.
7. The method of claim 5, wherein, When the matrigel is matrigel, the volume concentration of the matrigel is 70-90% in step 1 in which the organoid suspension is mixed with the matrigel.
8. The method of claim 7, wherein, The volume concentration of the matrigel is 80-90%.
9. The method of claim 8, wherein, The volume concentration of the matrigel is 80%.
10. The method of claim 7, wherein, In step 3, the time for the organoid to sink to the surface of the matrigel under the action of gravity is 5-15 minutes.
11. The method of claim 10, wherein, In step 3, the time for the organoid to sink to the surface of the matrgel under the action of gravity is 10-15 minutes.
12. The method of claim 11, wherein, In step 3, the time for the organoid to sink to the matrigel surface under the action of gravity is 10 minutes.
Citation Information
Patent Citations
Superhydrophobic micro-pit array chip and its fabrication method and apparatus
CN111701629B
Method for constructing 3D liver bud organoid based on framework nucleic acid material and use of 3D liver bud organoid
CN113717928A
